Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 75
Filtrar
1.
Ren Fail ; 40(1): 187-195, 2018 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-29619875

RESUMO

Based on successful targeting to the αvß3 integrin of cyclic arginine-glycine-aspartic acid (cRGD), cRGD-conjugated small interfering RNA (siRNA) exhibits tumor targeting and has become a new treatment strategy for solid tumors. However, the nephrotoxicity caused by its renal retention limits its clinical application. Here, we evaluated the protective effect of Gelofusine against cRGD-conjugated siRNA-induced nephrotoxicity in mice. Male Kunming mice (six per group) were either co-injected with Gelofusine and cRGD-siRNA or injected with cRGD-siRNA alone. After administration of these treatments five times, creatinine and blood urea nitrogen (BUN) levels were determined. Hematoxylin-eosin staining (HE staining) and transferase dUTP nick end labeling (TUNEL) analysis were used to compare the difference in renal damage between the groups. Additionally, fluorescence imaging was used to observe the distribution of cRGD-siRNA in vivo. The group co-injected with Gelofusine and cRGD-siRNA displayed lower creatinine and BUN levels than the cRGD-siRNA-alone group and showed less renal damage upon HE staining and TUNEL analysis. Gelofusine decreased the retention time and accelerated the elimination of cRGD-siRNA from the organs, as observed in the fluorescence images. These data indicate that Gelofusine significantly increased the excretion of cRGD-conjugated siRNA and reduced the associated renal damage.


Assuntos
Injúria Renal Aguda/prevenção & controle , Rim/efeitos dos fármacos , Poligelina/uso terapêutico , RNA Interferente Pequeno/imunologia , Eliminação Renal/efeitos dos fármacos , Injúria Renal Aguda/imunologia , Animais , Linhagem Celular Tumoral , Modelos Animais de Doenças , Sistemas de Liberação de Medicamentos , Humanos , Integrina alfaVbeta3/genética , Rim/metabolismo , Masculino , Camundongos , Peptídeos Cíclicos/administração & dosagem , Peptídeos Cíclicos/química , Peptídeos Cíclicos/toxicidade , Poligelina/farmacologia , RNA Interferente Pequeno/administração & dosagem , RNA Interferente Pequeno/química , RNA Interferente Pequeno/genética , Distribuição Tecidual
2.
Rev Med Chir Soc Med Nat Iasi ; 118(1): 232-8, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24741806

RESUMO

AIM: To study effects of a perfluorocarbon emulsion on plasma and whole human blood viscosity in the presence of albumin or modified fluid gelatin. MATERIAL AND METHODS: We investigated the effects of several PFC concentrations on plasma and whole blood viscosity in the presence of human albumin solution (HAS) or modified fluid gelatine (MFG; Gelofusine) to obtain three PFC emulsion concentrations (4, 8 and 15 g/dL). Three hematocrit levels (Hct) were investigated: 30, 20 and 13%, corresponding to different clinical situations. Plasma and whole blood viscosity was measured at 37 degrees C, using a Couette viscometer for shear rates ranging from 0.2 to128 s(-1). RESULTS AND DISCUSSION: All PFC concentrations increased plasma and whole blood viscosity for the same Hct. Viscosity values similar to physiological ones were observed at Hct 13%, with MFG - PFC 4, 8 g/dL and HAS - PFC 15 g/dL; at Hct 20%, with MFG - PFC 4g/dL and HAS - PFC 15 g/dL; at Hct 30%, and HAS - PFC 4, 8 g/dL. CONCLUSIONS: We conclude that this PFC emulsion increases plasma and blood viscosity and that among the three studied volume expanders, the interaction with MFG can result in viscosity values above the physiological one even at low Hct values. Our results suggest that such increased blood viscosity could decrease skeletal muscle oxygen pressure.


Assuntos
Viscosidade Sanguínea/efeitos dos fármacos , Sangue/efeitos dos fármacos , Fluorocarbonos/farmacologia , Emulsões/farmacologia , Fluorocarbonos/química , Hematócrito , Hemorreologia/efeitos dos fármacos , Humanos , Plasma/efeitos dos fármacos , Substitutos do Plasma/farmacologia , Poligelina/farmacologia
6.
Crit Care ; 16(2): R69, 2012 Dec 12.
Artigo em Inglês | MEDLINE | ID: mdl-22546374

RESUMO

INTRODUCTION: The correction of hypovolemia with acellular fluids results in acute normovolemic anemia. Whether the choice of the infusion fluid has an impact on the maintenance of oxygen (O2) supply during acute normovolemic anemia has not been investigated so far. METHODS: Thirty-six anesthetized and mechanically ventilated pigs were hemodiluted to their physiological limit of anemia tolerance, reflected by the individual critical hemoglobin concentration (Hbcrit). Hbcrit was defined as the Hb-concentration corresponding with the onset of supply-dependency of total body O2-consumption (VO2). The hemodilution protocol was randomly performed with either tetrastarch (6% HES 130/0.4, TS-group, n = 9), gelatin (3.5% urea-crosslinked polygeline, GEL-group, n = 9), hetastarch (6% HES 450/0.7, HS-group, n = 9) or Ringer's solution (RS-group, n = 9). The primary endpoint was the dimension of Hbcrit, secondary endpoints were parameters of central hemodynamics, O2 transport and tissue oxygenation. RESULTS: In each animal, normovolemia was maintained throughout the protocol. Hbcrit was met at 3.7 ± 0.6 g/dl (RS), 3.0 ± 0.6 g/dl (HS P < 0.05 vs. RS), 2.7 ± 0.6 g/dl (GEL, P < 0.05 vs. RS) and 2.1 ± 0.4 g/dl (TS, P < 0.05 vs. GEL, HS and RS). Hemodilution with RS resulted in a significant increase of extravascular lung water index (EVLWI) and a decrease of arterial oxygen partial pressure (paO2), and O2 extraction ratio was increased, when animals of the TS-, GEL- and HS-groups met their individual Hbcrit. CONCLUSIONS: The choice of the intravenous fluid has an impact on the tolerance of acute normovolemic anemia induced by acellular volume replacement. Third-generation tetrastarch preparations (e.g., HES 130/0.4) appear most advantageous regarding maintenance of tissue oxygenation during progressive anemia. The underlying mechanism includes a lower degree of extravasation and favourable effects on microcirculatory function.


Assuntos
Anemia/etiologia , Anemia/fisiopatologia , Hidratação/métodos , Hemodiluição/métodos , Hipovolemia/terapia , Análise de Variância , Animais , Volume Sanguíneo , Eletrocardiografia , Determinação de Ponto Final , Gelatina/farmacologia , Hemodinâmica/fisiologia , Hemoglobinas/análise , Derivados de Hidroxietil Amido/farmacologia , Soluções Isotônicas/farmacologia , Consumo de Oxigênio/fisiologia , Poligelina/farmacologia , Distribuição Aleatória , Análise de Regressão , Respiração Artificial , Solução de Ringer , Suínos
7.
Br J Anaesth ; 109(2): 168-76, 2012 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-22508964

RESUMO

BACKGROUND: This study aims to study changes in blood volume after 1 litre infusions of Gelofusine(®) [4% succinylated gelatine in 0.7% saline, weight-average molecular weight (MWw) 30 kDa] and Voluven(®) (6% hydroxyethyl starch in 0.9% saline, MWw 130 kDa) in the presence of increased capillary permeability. METHODS: In this randomized double-blind study, adults undergoing laparoscopic cholecystectomy received 1 litre of Gelofusine(®) (n=12) or Voluven(®) (n=13) over 1 h at the induction of anaesthesia. No other fluids were given. Haematocrit, serum electrolytes, and osmolality were measured before infusion and hourly thereafter for 4 h. Changes in blood volume were calculated from changes in haematocrit. The urinary albumin:creatinine ratio (ACR) was measured before and after operation. RESULTS: Baseline parameters before the two infusions were similar (P>0.050). The urinary ACR increased significantly after operation after Gelofusine(®) (P=0.011) and Voluven(®) (P=0.002), indicating increased capillary permeability. Voluven(®) produced a greater increase in serum chloride concentration (P=0.028) and a larger decrease in strong ion difference (P=0.009) than Gelofusine(®). There were no significant differences in changes in haematocrit (P=0.523) and blood volume (P=0.404) over the study period when the two infusions were compared, nor were there any differences in serum sodium, potassium, bicarbonate, and albumin concentrations (P>0.050). Urine output, sodium concentration, and osmolality were similar after the two infusions (P>0.050). CONCLUSIONS: The blood volume-expanding effects of the two colloids were not significantly different, despite the increase in postoperative urinary ACR and the 100 kDa difference in MWw.


Assuntos
Volume Sanguíneo/efeitos dos fármacos , Derivados de Hidroxietil Amido/farmacologia , Cuidados Intraoperatórios/métodos , Substitutos do Plasma/farmacologia , Poligelina/farmacologia , Adolescente , Adulto , Idoso , Volume Sanguíneo/fisiologia , Permeabilidade Capilar/fisiologia , Colecistectomia Laparoscópica , Método Duplo-Cego , Eletrólitos/sangue , Feminino , Hidratação/métodos , Hematócrito , Hemoglobinas/metabolismo , Humanos , Derivados de Hidroxietil Amido/administração & dosagem , Infusões Intravenosas , Masculino , Pessoa de Meia-Idade , Substitutos do Plasma/administração & dosagem , Poligelina/administração & dosagem , Adulto Jovem
8.
Cancer Sci ; 103(6): 1105-10, 2012 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-22448775

RESUMO

Integrin α(v)ß(3) expression is upregulated during tumor growth and invasion in newly formed endothelial cells in tumor neovasculature and in some tumor cells. A tetrameric RGD-based peptide, regioselectively addressable functionalized template-(cyclo-[RGDfK])4 (RAFT-RGD), specifically targets integrin α(v)ß(3) in vitro and in vivo. When labeled with indium-111, the RAFT-RGD is partially reabsorbed and trapped in the kidneys, limiting its use for further internal targeted radiotherapy and imaging investigations. We studied the effect of Gelofusine on RAFT-RGD renal retention in tumor-bearing mice. Mice were imaged using single photon emission computed tomography and optical imaging 1 and 24 h following tracer injection. Distribution of RAFT-RGD was further investigated by tissue removal and direct counting of the tracer. Kidney sections were analyzed by confocal microscopy. Gelofusine significantly induced a >50% reduction of the renal reabsorption of (111)In-DOTA-RAFT-RGD and A700-RAFT-RGD, without affecting tumor uptake. Injection of Gelofusine significantly reduced the renal retention of labeled RAFT-RGD, while increasing the tumor over healthy tissue ratio. These results will lead to the development of future therapeutic approaches.


Assuntos
Radioisótopos de Índio/farmacocinética , Integrina alfaVbeta3/metabolismo , Rim/metabolismo , Compostos Organometálicos/farmacocinética , Peptídeos Cíclicos/farmacocinética , Poligelina/farmacologia , Animais , Linhagem Celular Tumoral , Feminino , Corantes Fluorescentes , Células HEK293 , Humanos , Índio/metabolismo , Radioisótopos de Índio/metabolismo , Taxa de Depuração Metabólica , Camundongos , Camundongos Nus , Imagem Multimodal , Compostos Organometálicos/metabolismo , Peptídeos Cíclicos/metabolismo , Tomografia por Emissão de Pósitrons , Distribuição Tecidual , Tomografia Computadorizada por Raios X
9.
Contrast Media Mol Imaging ; 6(2): 85-92, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-20936711

RESUMO

BACKGROUND: Nanobodies are single-domain antigen binding fragments derived from functional heavy-chain antibodies elicited in Camelidae. They are powerful probes for radioimmunoimaging, but their renal uptake is relatively high. In this study we have evaluated the role of megalin on the renal uptake of anti-EGFR (99m)Tc-7C12 nanobody and the potency of gelofusine and/or lysine to reduce renal uptake of (99m)Tc-7C12. METHODS: First we compared the renal uptake of (99m)Tc-7C12 in megalin-deficient and megalin-wild-type mice using pinhole SPECT/microCT and ex vivo analysis. The effect of gelofusine and lysine administration on renal accumulation of (99m)Tc-7C12 was analyzed in CD-1 mice divided into lysine preload at 30 min before tracer injection (LysPreload), LysPreload + gelofusine coadministration (LysPreload + GeloCoad), lysine coadministration (LysCoad), gelofusine coadministration (GeloCoad) and LysCoad + GeloCoad. The combined effect of gelofusine and lysine on tumor uptake was tested in mice xenografts. RESULTS: Renal uptake of (99m)Tc-7C12 was 44.22 ± 3.46% lower in megalin-deficient compared with megalin-wild-type mice. In CD-1 mice, lysine preload had no effect on the renal retention whereas coinjection of lysine or gelofusine with the tracer resulted in 25.12 ± 2.99 and 36.22 ± 3.07% reduction, respectively. The combined effect of gelofusine and lysine was the most effective, namely a reduction of renal retention of 45.24 ± 2.09%. Gelofusine and lysine coadministration improved tumor uptake. CONCLUSION: Megalin contributes to the renal accumulation of (99m)Tc-7C12. Gelofusine and lysine coinjection with the tracer reduces the renal uptake while tumor uptake is improved. Although this methodology allows for optimization of imaging protocol using nanobodies, further improvements are needed before using these molecules for radionuclide therapy.


Assuntos
Receptores ErbB/imunologia , Rim/metabolismo , Anticorpos de Cadeia Única/química , Anticorpos de Cadeia Única/metabolismo , Tecnécio/química , Animais , Feminino , Rim/efeitos dos fármacos , Proteína-2 Relacionada a Receptor de Lipoproteína de Baixa Densidade/genética , Proteína-2 Relacionada a Receptor de Lipoproteína de Baixa Densidade/metabolismo , Lisina/farmacologia , Camundongos , Camundongos Endogâmicos C57BL , Poligelina/farmacologia , Anticorpos de Cadeia Única/imunologia
10.
Am J Physiol Heart Circ Physiol ; 300(2): H685-92, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-21148761

RESUMO

Small volume hypertonic saline resuscitation can be beneficial for treating hemorrhagic shock, but the mechanism remains poorly defined. We investigated the effects of hemorrhagic resuscitation with hypertonic saline on cardiac (CSNA) and renal sympathetic nerve activity (RSNA) and the resulting cardiovascular consequences. Studies were performed on conscious sheep instrumented with cardiac (n=7) and renal (n=6) sympathetic nerve recording electrodes and a pulmonary artery flow probe. Hemorrhage (20 ml/kg over 20 min) caused hypotension and tachycardia followed by bradycardia, reduced cardiac output, and abolition of CSNA and RSNA. Resuscitation with intravenous hypertonic saline (1.2 mol/l at 2 ml/kg) caused rapid, dramatic increases in mean arterial pressure, heart rate, and CSNA, but had no effect on RSNA. In contrast, isotonic saline resuscitation (12 ml/kg) had a much delayed and smaller effect on CSNA, less effect on mean arterial pressure, no effect on heart rate, but stimulated RSNA, although the plasma volume expansion was similar. Intracarotid infusion of hypertonic saline (1 ml/min bilaterally, n=5) caused similar changes to intravenous administration, indicating a cerebral component to the effects of hypertonic saline. In further experiments, contractility (maximum change in pressure over time), heart rate, and cardiac output increased significantly more with intravenous hypertonic saline (2 ml/kg) than with Gelofusine (6 ml/kg) after hemorrhage; the effects of hypertonic saline were attenuated by the ß-receptor antagonist propranolol (n=6). These results demonstrate a novel neural mechanism for the effects of hypertonic saline resuscitation, comprising cerebral stimulation of CSNA by sodium chloride to improve cardiac output by increasing cardiac contractility and rate and inhibition of RSNA.


Assuntos
Coração/inervação , Hemorragia/fisiopatologia , Hemorragia/terapia , Rim/inervação , Ressuscitação , Solução Salina Hipertônica/uso terapêutico , Sistema Nervoso Simpático/fisiologia , Antagonistas Adrenérgicos beta/farmacologia , Animais , Pressão Sanguínea/efeitos dos fármacos , Pressão Sanguínea/fisiologia , Química Encefálica/efeitos dos fármacos , Feminino , Coração/fisiologia , Hemodinâmica/efeitos dos fármacos , Hemodinâmica/fisiologia , Soluções Isotônicas/farmacologia , Rim/fisiologia , Contração Miocárdica/efeitos dos fármacos , Poligelina/farmacologia , Propranolol/farmacologia , Ovinos , Estimulação Química , Sistema Nervoso Simpático/efeitos dos fármacos
11.
Gastrointest Endosc ; 71(3): 589-95, 2010 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-20189519

RESUMO

BACKGROUND: Succinylated gelatin (SG) is an inexpensive colloid that may combine ease of use with the advantages of a colloid to potentially increase EMR specimen size, leading to a higher rate of en bloc resection. OBJECTIVE: To evaluate the safety, efficacy, and impact on EMR specimen size of SG as a submucosal (s.m.) injectant in comparison with normal saline solution (NS). DESIGN: Randomized, blinded, controlled trial conducted with Animal Ethics Committee approval. SETTING: Academic hospital. SUBJECTS: Ten swine. INTERVENTIONS: Sixty EMRs (30 using SG vs 30 using NS as 3 paired experiments per animal) of the largest possible en bloc snare resection of normal colonic mucosa after s.m. injection of a fixed volume of either SG or NS. MAIN OUTCOME MEASUREMENTS: EMR specimen size, duration of s.m. cushion, duration of procedure, ratio of vertical elevation to lateral spread of injectant, ease of resection, adverse effects, perforation, histopathology of EMR sites in colectomy specimens at necropsy (for inflammatory cell content, depth of ulceration, and vascular or ischemic changes). RESULTS: The mean subject weight was 53 kg. The mean EMR specimen dimensions and surface area were significantly larger with SG (length 37 vs 31 mm, P = .031; width 32 vs 26 mm, P = .022; surface area 9.5 cm(2) vs 6.7 cm(2), P = .044, respectively). The median s.m. cushion duration was 60 minutes with SG versus 15 minutes with NS (P = .005). The median procedure duration with SG was 2.6 minutes vs 2.5 minutes with NS (P = .515). The ratio of vertical elevation to lateral spread of injectant (mean score on a 3-point scale) was 3 with SG versus 2 with NS (P = .228). Ease of resection score (mean score on a 10-point scale) was 8 with SG versus 7 with NS (P = .216). There were no systemic adverse effects, hypersensitivity reactions, or bleeding episodes. There were 2 perforations (treated with clips) with SG and 1 with NS (P = 1.0). Blinded histopathologist assessment of necropsy colectomy specimens did not identify any significant differences between SG and NS EMR sites. LIMITATIONS: Animal study. CONCLUSIONS: SG is safe and results in a 42% increased surface area for en bloc EMR. Given its other favorable properties, it represents a significant step toward defining the ideal EMR solution.


Assuntos
Colo/cirurgia , Gelatina/farmacologia , Mucosa Intestinal/cirurgia , Substitutos do Plasma/farmacologia , Poligelina/farmacologia , Succinatos/farmacologia , Animais , Endoscopia Gastrointestinal/métodos , Modelos Animais , Suínos
12.
Crit Care Med ; 38(2): 464-70, 2010 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19789444

RESUMO

OBJECTIVE: To study the changes in blood volume and hormones controlling sodium and water homeostasis after infusions of 0.9% saline, Gelofusine (4% succinylated gelatin in 0.7% saline, weight-average molecular weight 30 kD), and Voluven (6% hydroxyethyl starch in 0.9% saline, weight-average molecular weight 130 kD) in healthy volunteers. DESIGN: Randomized, three-way crossover study. SETTING: University teaching hospital. SUBJECTS: Ten healthy adult male volunteers. INTERVENTIONS: Volunteers received 1-L infusions of 0.9% saline, Gelofusine, and Voluven over 1 hr on three occasions. Body weight, hematocrit, serum biochemistry, and plasma concentrations of vasopressin, aldosterone, brain natriuretic peptide, and total renin were measured before infusion and hourly thereafter for 6 hrs. Changes in body water, blood volume, and extravascular fluid volume were calculated. MEASUREMENTS AND MAIN RESULTS: Although changes in body weight (total body water) after the infusions were similar, blood volume expansion by the two colloids was significantly greater than that produced by 0.9% saline (p < .01). At the end of infusions, 68%, 21%, and 16% of the infused volumes of 0.9% saline, Gelofusine, and Voluven, respectively, had escaped from the intravascular space to the extravascular space. Over the 6 hrs, the magnitude and duration of blood volume expansion by the two colloids were similar (p = .70). There were no significant differences in urinary volume, osmolality, and sodium content after the three infusions. Hormonal changes were similar after the three infusions, with the increase in natriuretic peptide being transient. The reduction in aldosterone and total renin concentrations was more sustained. CONCLUSIONS: The effects of Gelofusine and Voluven were similar despite the 100 kD difference in weight-average molecular weight. Excretion of an acute fluid load containing sodium and chloride may be dependent on a sustained suppression of the renin-angiotensin-aldosterone system rather than on natriuretic peptides.


Assuntos
Volume Sanguíneo/efeitos dos fármacos , Derivados de Hidroxietil Amido/farmacologia , Substitutos do Plasma/farmacologia , Poligelina/farmacologia , Cloreto de Sódio/farmacologia , Adulto , Aldosterona/sangue , Volume Sanguíneo/fisiologia , Água Corporal/efeitos dos fármacos , Estudos Cross-Over , Hematócrito , Humanos , Derivados de Hidroxietil Amido/administração & dosagem , Infusões Intravenosas , Masculino , Peptídeo Natriurético Encefálico/sangue , Substitutos do Plasma/administração & dosagem , Poligelina/administração & dosagem , Renina/sangue , Cloreto de Sódio/administração & dosagem , Vasopressinas/sangue , Equilíbrio Hidroeletrolítico/efeitos dos fármacos , Equilíbrio Hidroeletrolítico/fisiologia
13.
J Crit Care ; 25(2): 361.e1-5, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19682845

RESUMO

BACKGROUND: Hypovolemia is a common clinical entity in critical patients, and adequate volume replacement therapy seems to be essential for maintaining tissue perfusion. However, it is still uncertain which solution is most appropriate for fluid resuscitation. OBJECTIVE: The aim of this study was to investigate the effects of fluid resuscitation with 3.5% polygeline versus 6% hydroxyethyl starch solutions on hemodynamic functions and liver functions assessed with a noninvasive liver function monitoring system (LIMON) in hypovolemic patients. DESIGN: This study is a prospective randomized clinical trial. MEASUREMENTS AND RESULTS: Thirty hypovolemic patients (intrathoracic blood volume index, <850 mL/m(2)) were randomized into hydroxyethyl starch (mean molecular weight, 130,000 Da) and polygeline (mean molecular weight, 30,000 Da) groups (15 patients each). Indocyanine green plasma disappearance elimination (ICG-PDR) were conducted concurrently using LIMON. A dose of 0.3 mg/kg ICG was given through a cubital fossa vein as a bolus. For fluid resuscitation, 500 mL of colloid was given to the patients. Repeated hemodynamic and ICG-PDR measurements were done at baseline, after infusion, and then at 30 minutes after infusion. RESULTS: Intrathoracic blood volume index and systolic, diastolic, and mean blood pressures increased significantly after infusion and remained elevated for 30 minutes after infusion, but there was no significant difference between the 2 groups. Indocyanine green plasma disappearance elimination values were similar in both groups with no significant difference between the two. CONCLUSION: Increasing intrathoracic blood volume index and hemodynamic variables by fluid loading is not associated with a significant change in ICG-PDR.


Assuntos
Hidratação/métodos , Derivados de Hidroxietil Amido/farmacologia , Hipovolemia/terapia , Circulação Hepática/efeitos dos fármacos , Substitutos do Plasma/farmacologia , Poligelina/farmacologia , Corantes , Feminino , Hemodinâmica/efeitos dos fármacos , Humanos , Derivados de Hidroxietil Amido/uso terapêutico , Verde de Indocianina , Testes de Função Hepática , Masculino , Pessoa de Meia-Idade , Substitutos do Plasma/uso terapêutico , Poligelina/uso terapêutico , Estudos Prospectivos , Resultado do Tratamento
14.
Med Sci Monit ; 15(10): BR293-300, 2009 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-19789506

RESUMO

BACKGROUND: Multiple blood sampling in rat pharmacokinetic (PK) and toxicokinetic studies can result in a pathophysiological response and misleading data interpretation. This study investigated whether these drawbacks can be minimized by replacing withdrawn blood with saline, gelofusine, or donor blood. MATERIAL/METHODS: Rats with cannulated jugular veins were subjected to 12 withdrawals of 250 and 500 microl of blood followed by replacement with the same amount of saline, gelofusine, or donor blood. Red blood cell, hematocrit, hemoglobin, total protein, albumin, glucose, Na, and Cl levels were determined in the drawn blood. RESULTS: Multiple blood sampling caused a time-dependent decrease in red blood cell counts and hematocrit, hemoglobin, total protein, and albumin levels in all the treatment groups, but these effects were significantly alleviated in the blood-treated group. Withdrawal of 500 microl of blood caused more pronounced changes than 250 microl blood withdrawal in the saline- and gelofusine-treatment groups, but not in the blood-treatment group. Plasma glucose and Na remained unchanged in all the treatment groups, while slight changes in Cl levels were observed in the saline- and gelofusine-treatment groups. CONCLUSIONS: Blood sample volume had a crucial impact on the measured parameters, which were least affected in the donor blood-treated group. Regardless of the treatment, up to five 250 microl blood samples can be drawn without causing significant changes in a rat's normal condition. However, for a proper determination of PK profile, more than five blood samples are required and therefore drawn blood should be replaced, preferably with donor blood.


Assuntos
Fenômenos Fisiológicos Sanguíneos/efeitos dos fármacos , Coleta de Amostras Sanguíneas/métodos , Transfusão de Sangue , Poligelina/farmacologia , Cloreto de Sódio/farmacologia , Animais , Glicemia/efeitos dos fármacos , Cloretos/sangue , Contagem de Eritrócitos , Hematócrito , Hemoglobinas/metabolismo , Masculino , Ratos , Ratos Wistar , Sódio/sangue , Fatores de Tempo
15.
Eur J Nucl Med Mol Imaging ; 36(12): 1968-76, 2009 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19585115

RESUMO

PURPOSE: Peptide receptor radionuclide therapy using ß-emitting radiolabelled somatostatin analogues like DOTA,Tyr3-octreotate shows beneficial results in patients suffering from somatostatin receptor overexpressing tumours. However, after high-dose therapy partial renal reabsorption of radiopeptides may lead to nephrotoxicity. Co-infusion of lysine/arginine lowers renal retention of these radiopeptides without affecting tumour uptake. Recently co-administration of Gelofusine has been described to have a comparable kidney-protecting effect in rats. In the present study optimal dosing of Gelofusine co-administration was studied in tumour-bearing rats. METHODS: Doses of 40, 80, 120 or 160 mg/kg Gelofusine were co-injected with 15 µg DOTA,Tyr3-octreotate, labelled with 3 MBq 111In for biodistribution (24 h post-injection, n = 4 per group) and with 60 MBq 111In for microSPECT imaging experiments at 3, 24 and 48 h post-injection. An additional group of rats received 80 mg/kg Gelofusine plus 400 mg/kg lysine co-injection. Biodistribution studies were performed both in older (475 g) and younger (300 g) rats, the latter bearing CA20948 tumours. RESULTS: Co-injection of 40 mg/kg Gelofusine resulted in 40-50% reduction of renal uptake and retention of 111In-DOTA,Tyr3-octreotate, whereas higher doses further increased the reduction to 50-60% in both groups of rats. Combining Gelofusine and lysine caused 70% reduction of renal uptake. The uptake of radiolabelled octreotate both in somatostatin receptor-expressing normal tissues and tumours was not affected by Gelofusine co-injection. CONCLUSION: In rats co-injection of 80 mg/kg Gelofusine resulted in maximum reduction of renal retention of 111In-DOTA,Tyr3-octreotate, which was further improved when combined with lysine. Tumour uptake of radiolabelled octreotate was not affected, resulting in an increased tumour to kidney ratio.


Assuntos
Rim/efeitos dos fármacos , Rim/metabolismo , Neoplasias Pancreáticas/patologia , Peptídeos Cíclicos/metabolismo , Poligelina/farmacologia , Animais , Transporte Biológico/efeitos dos fármacos , Linhagem Celular Tumoral , Transformação Celular Neoplásica , Relação Dose-Resposta a Droga , Regulação Neoplásica da Expressão Gênica , Marcação por Isótopo , Masculino , Neoplasias Pancreáticas/diagnóstico por imagem , Neoplasias Pancreáticas/metabolismo , Peptídeos Cíclicos/farmacocinética , Ratos , Receptores de Somatostatina/metabolismo , Distribuição Tecidual/efeitos dos fármacos , Tomografia Computadorizada de Emissão de Fóton Único , Tomografia Computadorizada por Raios X
16.
Nuklearmedizin ; 47(3): 110-5, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18493690

RESUMO

AIM: In peptide receptor radionuclide therapy (PRRT) using radiolabelled somatostatin analogues, kidney uptake of radiolabelled compound is the major dose-limiting factor. We studied the effects of Gelofusine (20 mg) and lysine (100 mg) and the combination of both after injection of therapeutic doses of radiolabelled [DOTA0,Tyr3]octreotate (60 MBq 111In or 555 MBq 177Lu labelled to 15 microg peptide) in male Lewis rats. METHODS: Kidney uptake was measured by single photon emission computed tomography (SPECT) scans with a four-headed multi-pinhole camera (NanoSPECT) at 24 h, 5 and 7 days p. i. and was quantified by volume of interest analysis. For validation the activity concentration in the dissected kidneys was also determined ex vivo using a gamma counter and a dose calibrator. RESULTS: Gelofusine and lysine both reduced kidney uptake of [177Lu-DOTA0,Tyr3]octreotate significantly by about 40% at all time points. The combination of Gelofusine and lysine resulted in a 62% inhibition of kidney uptake (p < 0.01 vs. lysine alone). A weak but significant dose-response relationship for Gelofusine, but not for lysine, was found. In a study with [111In-DOTA0,Tyr3]octreotate, conclusions drawn from NanoSPECT data were confirmed by biodistribution data. CONCLUSIONS: We conclude that rat kidney uptake of radiolabelled somatostatin analogues can be monitored for a longer period in the same animal using animal SPECT. Gelofusine and lysine had equal potential to reduce kidney uptake of therapeutic doses of [177Lu-DOTA0,Tyr3]octreotate. The combination of these compounds caused a significantly larger reduction than lysine or Gelofusine alone and may therefore offer new possibilities in PRRT. The NanoSPECT data were validated by standard biodistribution experiments.


Assuntos
Rim/diagnóstico por imagem , Rim/metabolismo , Lutécio , Lisina/farmacologia , Octreotida/análogos & derivados , Compostos Organometálicos , Poligelina/farmacologia , Animais , Transporte Biológico/efeitos dos fármacos , Hipersensibilidade a Drogas , Humanos , Rim/efeitos dos fármacos , Lutécio/farmacocinética , Octreotida/farmacocinética , Compostos Organometálicos/farmacocinética , Poligelina/efeitos adversos , Radioisótopos/farmacocinética , Ratos , Tomografia Computadorizada de Emissão de Fóton Único/métodos
17.
Eur J Nucl Med Mol Imaging ; 35(1): 53-64, 2008 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-17891393

RESUMO

PURPOSE: Among gynecologic malignancies, ovarian cancer has the highest mortality due to rapid peritoneal dissemination. Treatment failure particularly arises from failure to eliminate disseminated cells. Our aim was to develop peptidic radioligands targeting tumour cell-associated urokinase receptor (uPAR, CD87) for alpha-emitter therapy for advanced ovarian cancer. METHODS: DOTA-conjugated, uPAR-directed ligands were synthesised on solid-phase. Binding of peptides to human cells expressing uPAR was assayed by flow cytofluorometry or, in case of (213)Bi-labelled peptides, by measuring cell-bound radioactivity. Bio-distribution of the (213)Bi-labelled peptide P-P4D was analysed in nude mice 28 days after intraperitoneal inoculation of OV-MZ-6 ovarian cancer cells in the absence or presence of the plasma expander gelofusine. RESULTS: uPAR-selective ligands were developed based on published high-affinity uPAR-binding peptides. For preparation of N-terminally cross-linked divalent ligands, a novel solid-phase procedure was developed. Specific binding of (213)Bi-labelled peptides to monocytoid U937 and OV-MZ-6 cells was demonstrated using the natural ligand of uPAR, pro-uPA, or a soluble form of uPAR, suPAR, as competitors. The pseudo-symmetrical covalent dimer (213)Bi-P-P4D displayed superior binding to OV-MZ-6 cells in vitro. Accumulation of (213)Bi-P-P4D in tumour tissue was demonstrated by bio-distribution analysis in nude mice bearing intraperitoneal OV-MZ-6-derived tumours. Gelofusine reduced kidney uptake of (213)Bi-P-P4D by half. CONCLUSION: Ovarian cancer cells overexpressing uPAR were specifically targeted in vitro and in vivo by (213)Bi-P-P4D. Kidney uptake of (213)Bi-P-P4D was distinctly reduced using gelofusine. Thus, this radiopeptide may represent a promising option for therapy for disseminated ovarian cancer.


Assuntos
Partículas alfa/uso terapêutico , Neoplasias Ovarianas/metabolismo , Neoplasias Ovarianas/radioterapia , Peptídeos/química , Peptídeos/metabolismo , Receptores de Ativador de Plasminogênio Tipo Uroquinase/metabolismo , Animais , Bismuto/química , Linhagem Celular Tumoral , Dimerização , Descoberta de Drogas , Inibidores Enzimáticos/química , Feminino , Regulação Neoplásica da Expressão Gênica , Compostos Heterocíclicos com 1 Anel/química , Humanos , Rim/efeitos dos fármacos , Rim/metabolismo , Ligantes , Camundongos , Metástase Neoplásica , Neoplasias Ovarianas/genética , Neoplasias Ovarianas/patologia , Peptídeos/síntese química , Peptídeos/farmacocinética , Poligelina/farmacologia , Radioisótopos , Receptores de Ativador de Plasminogênio Tipo Uroquinase/antagonistas & inibidores , Receptores de Ativador de Plasminogênio Tipo Uroquinase/química , Solubilidade , Especificidade por Substrato , Distribuição Tecidual
18.
J Clin Gastroenterol ; 41 Suppl 3: S262-5, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17975475

RESUMO

Previous studies, exploring the effect of blood viscosity on portal pressure in portal hypertensive humans and animal models, have shown conflicting results. In a series of studies, in portal vein constricted rats, we investigated effects of reduced blood viscosity on the hyperdynamic circulation, portal pressure, and vascular geometry. Blood was withdrawn at a rate of 0.3 mL/min for 15 minutes followed by 15 minutes of stabilization. The shed blood or Haemaccel was infused at the same rate and volume as used for withdrawal. Hemodynamic measurements were performed using radioactive microspheres. Blood viscosity was measured with an Ostwald viscometer. Vascular hindrance (reflecting vessel geometry) was calculated as resistance/viscosity ratio. In normal and portal hypertensive rats, acute volume replacement with Haemaccel, induced increase in systemic and splanchnic blood flows reflecting mainly changes in viscosity and not in blood vessel geometry. However, 24 hours later, in Haemaccel treated animals, an increased splanchnic arteriolar and porto-collateral vascular hindrance were observed. This indicated vasoconstriction in the porto-collateral vascular bed. The increase in portal venous inflow after acute volume restitution with Haemaccel was prevented by pretreatment with propranolol. Although, caution should be taken in extrapolating these results to humans, we would like to speculate that during a portal hypertensive-related bleeding episode: (1) volume replacement with low viscosity plasma expanders may aggravate the hyperdynamic circulation of portal hypertension. (2) Slow rate volume replacement enables hemodynamic adaptation to occur. (3) Volume replacement maybe more safe in a subject pretreated with propranolol.


Assuntos
Viscosidade Sanguínea , Varizes Esofágicas e Gástricas/complicações , Hemorragia Gastrointestinal/etiologia , Hipertensão Portal/sangue , Substitutos do Plasma/farmacologia , Poligelina/farmacologia , Pressão na Veia Porta/efeitos dos fármacos , Circulação Esplâncnica/efeitos dos fármacos , Antagonistas Adrenérgicos beta/farmacologia , Animais , Circulação Colateral/efeitos dos fármacos , Modelos Animais de Doenças , Varizes Esofágicas e Gástricas/sangue , Varizes Esofágicas e Gástricas/etiologia , Varizes Esofágicas e Gástricas/fisiopatologia , Hemorragia Gastrointestinal/sangue , Hemorragia Gastrointestinal/tratamento farmacológico , Hemorragia Gastrointestinal/fisiopatologia , Humanos , Hipertensão Portal/complicações , Hipertensão Portal/fisiopatologia , Substitutos do Plasma/efeitos adversos , Poligelina/efeitos adversos , Propranolol/farmacologia , Ratos , Resistência Vascular/efeitos dos fármacos , Vasoconstrição/efeitos dos fármacos
19.
Zhonghua Yi Xue Za Zhi ; 87(27): 1908-11, 2007 Jul 17.
Artigo em Chinês | MEDLINE | ID: mdl-17923015

RESUMO

OBJECTIVE: To observe the effect of hydroxyethyl starch (HES) 130/0.4 on S100B protein level and cerebral metabolism of oxygen in open cardiac surgery under cardiopulmonary bypass (CPB) and to explore whether it has the protective effect of 6%HES130/0.4 as priming solution on cerebral injury during CPB and explore the probable mechanism. METHODS: Forty patients with atrioseptal defect or ventricular septal defect scheduled for elective surgical repair under CPB with moderate hypothermia were randomly divided into two equal groups: HES 130/0.4 group (HES group) in which HES 130/0.4 (voluven) was used as priming solution and gelatin group (GRL group) in which gelofusine (succinylated gelatin) was used as priming solution. ECG, heart rate (HR), blood pressure (BP), mean arterial pressure (MAP), central venous pressure (CVP), arterial partial pressure of oxygen (P(a)O(2),), arterial partial pressure of carbon dioxide (P(et)CO(2)) and body temperature (naso-pharyngeal and rectal) were continuously monitored during the operation. Blood samples were obtained from the central vein for determination of blood concentrations of S100B protein at the following time points: before CPB (T(0)), 20 minutes after the beginning of CPB (T(1)), immediately after the termination of CPB (T(2)), 60 minutes after the termination of CPB (T(3)), and 24 hours after the termination of CPB (T(4)). The serum S100B protein levels were measured by ELISA. At the same time points blood samples were obtained from the jugular vein and radial artery to undergo blood gas analysis and measurement of blood glucose, based on which the cerebral oxygen metabolic rate/cerebral metabolic rate of glucose (CMRO(2)/CMR(GLU)) was calculated. RESULTS: Compared with the time point of immediately before CPB (T(0)), The S100B protein level of the 2 groups began to increase since the time point T(1), peaked at the time point T(2), began to decrease gradually since the time point T(3), and were still significantly higher than those before CPB at the time point T(4) (all P < 0.01), and the S100B protein levels at different time points of the HES group were all significantly lower than those of the GEL group (all P < 0.01). The S(jv)O(2) and CMRO(2)/CMR(GLU) levels of both groups increased at the time point T(1), decreased at the time points T(2) and T(3), and then restored to normal at the time points T(4). In the GEL group there were no significant differences in the levels between any 2 different time points, however, in the HES group S(jv)O(2) and CMRO(2)/CMR(GLU) levels at T(1) was significantly higher than those at the other time points (P < 0.05 or P < 0.01). CONCLUSION: S100B protein increases significantly in open cardiac surgery under CPB. HES130/0.4 lowers the S100B protein levels from the beginning of CPB to one hour after the termination of CPB with the probable mechanism of improving the cerebral metabolism of oxygen. 6%HES130/0.4 as priming solution may play a protective role in reduction of cerebral injury during CPB and open cardiac surgery.


Assuntos
Encéfalo/efeitos dos fármacos , Ponte Cardiopulmonar/métodos , Derivados de Hidroxietil Amido/farmacologia , Fatores de Crescimento Neural/sangue , Oxigênio/metabolismo , Proteínas S100/sangue , Adolescente , Adulto , Anestesia/métodos , Encéfalo/metabolismo , Eletrocardiografia , Feminino , Humanos , Derivados de Hidroxietil Amido/administração & dosagem , Masculino , Pessoa de Meia-Idade , Poligelina/administração & dosagem , Poligelina/farmacologia , Subunidade beta da Proteína Ligante de Cálcio S100
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...